Annual Working Capital
-$4.54 M
-$12.19 M-159.41%
31 December 2023
Summary:
CNS Pharmaceuticals annual working capital is currently -$4.54 million, with the most recent change of -$12.19 million (-159.41%) on 31 December 2023. During the last 3 years, it has fallen by -$18.13 million (-133.42%). CNSP annual working capital is now -133.42% below its all-time high of $13.59 million, reached on 31 December 2020.CNSP Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$3.33 M
+$7.95 M+172.14%
30 September 2024
Summary:
CNS Pharmaceuticals quarterly working capital is currently $3.33 million, with the most recent change of +$7.95 million (+172.14%) on 30 September 2024. Over the past year, it has increased by +$5.34 million (+265.98%). CNSP quarterly working capital is now -75.62% below its all-time high of $13.66 million, reached on 31 March 2022.CNSP Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CNSP Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -159.4% | +266.0% |
| 3 y3 years | -133.4% | -61.9% |
| 5 y5 years | -604.7% | +10000.0% |
CNSP Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -133.4% | at low | -75.6% | +172.1% |
| 5 y | 5 years | -133.4% | at low | -75.6% | +172.1% |
| alltime | all time | -133.4% | at low | -75.6% | +172.1% |
CNS Pharmaceuticals Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $3.33 M(-172.1%) |
| June 2024 | - | -$4.62 M(+2.8%) |
| Mar 2024 | - | -$4.49 M(-1.1%) |
| Dec 2023 | -$4.54 M(-159.4%) | -$4.54 M(+126.3%) |
| Sept 2023 | - | -$2.01 M(-196.8%) |
| June 2023 | - | $2.07 M(-32.0%) |
| Mar 2023 | - | $3.05 M(-60.1%) |
| Dec 2022 | $7.64 M(+56.5%) | $7.64 M(+2.5%) |
| Sept 2022 | - | $7.46 M(-28.8%) |
| June 2022 | - | $10.47 M(-23.3%) |
| Mar 2022 | - | $13.66 M(+179.8%) |
| Dec 2021 | $4.88 M | $4.88 M(-44.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $8.75 M(-27.4%) |
| June 2021 | - | $12.05 M(+10.7%) |
| Mar 2021 | - | $10.88 M(-19.9%) |
| Dec 2020 | $13.59 M(+79.2%) | $13.59 M(+577.7%) |
| Sept 2020 | - | $2.01 M(-45.7%) |
| June 2020 | - | $3.69 M(-36.9%) |
| Mar 2020 | - | $5.85 M(-22.8%) |
| Dec 2019 | $7.58 M(-1276.6%) | $7.58 M(<-9900.0%) |
| Sept 2019 | - | -$7300.00(-102.2%) |
| June 2019 | - | $338.50 K(-152.5%) |
| Dec 2018 | -$644.50 K(+1001.7%) | -$644.50 K |
| Dec 2017 | -$58.50 K | - |
FAQ
- What is CNS Pharmaceuticals annual working capital?
- What is the all time high annual working capital for CNS Pharmaceuticals?
- What is CNS Pharmaceuticals annual working capital year-on-year change?
- What is CNS Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for CNS Pharmaceuticals?
- What is CNS Pharmaceuticals quarterly working capital year-on-year change?
What is CNS Pharmaceuticals annual working capital?
The current annual working capital of CNSP is -$4.54 M
What is the all time high annual working capital for CNS Pharmaceuticals?
CNS Pharmaceuticals all-time high annual working capital is $13.59 M
What is CNS Pharmaceuticals annual working capital year-on-year change?
Over the past year, CNSP annual working capital has changed by -$12.19 M (-159.41%)
What is CNS Pharmaceuticals quarterly working capital?
The current quarterly working capital of CNSP is $3.33 M
What is the all time high quarterly working capital for CNS Pharmaceuticals?
CNS Pharmaceuticals all-time high quarterly working capital is $13.66 M
What is CNS Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, CNSP quarterly working capital has changed by +$5.34 M (+265.98%)